1. Nicolson, G. L. & Ash, M. E. Lipid Replacement Therapy: a natural medicine approach to replacing damaged lipids in cellular membranes and organelles and restoring function. Biochim. Biophys. Acta 1838, 1657–1679 (2014).
2. Nicolson, G. L. & Ellithorpe, R. Lipid Replacement and Antioxidant Nutritional Therapy for Restoring Mitochondrial Function and Reducing Fatigue in Chronic Fatigue Syndrome and Other Fatiguing Illnesses. J. Chronic Fatigue Syndr. 13, 57–68 (2006).
3. L. Nicolson, G., Settineri, R. & Ellithorpe, R. Lipid Replacement Therapy with a Glycophospholipid Formulation with NADH and CoQ10 Significantly Reduces Fatigue in Intractable Chronic Fatiguing Illnesses and Chronic Lyme Disease Patients. IJCM 03, 163–170 (2012).
4. Agadjanyan, M. et al. Nutritional Supplement (NT FactorTM) Restores Mitochondrial Function and Reduces Moderately Severe Fatigue in Aged Subjects. J. Chronic Fatigue Syndr. 11, 23–36 (2003).
5. Nicolson, G. L. & Conklin, K. A. Reversing mitochondrial dysfunction, fatigue and the adverse effects of chemotherapy of metastatic disease by molecular replacement therapy. Clin. Exp. Metastasis 25, 161– 169 (2008).
6. Nicolson, G. L. Lipid replacement/antioxidant therapy as an adjunct supplement to reduce the adverse effects of cancer therapy and restore mitochondrial function. Pathol. Oncol. Res. 11, 139–144 (2005).
7. Malmsten, C., et al., Dietary Supplementation with Astaxanthin-Rich Algal Meal Improves Strength Endurance
8. Kidd, P., Astaxanthin, Cell Membrane Nutrient with Diverse Clinical Benefits and Anti-Aging Potential
9. Daniells, S, (2015) Astaxanthin may extend endurance by boosting mitochondrial action
10. Yu, T., Dohl, J., Chen, Y., Gasier, H. G. & Deuster, P. A. Astaxanthin but not quercetin preserves mitochondrial integrity and function, ameliorates oxidative stress, and reduces heat‐induced skeletal muscle injury. Journal of Cellular Physiology vol. 234 13292–13302 (2019).
11. The power of natural astaxanthin for increased muscle performance.
12. Pashkow, F. J., Watumull, D. G. & Campbell, C. L. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am. J. Cardiol. 101, 58D–68D (2008).
13. Goulinet, S. & Chapman, M. J. Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 17, 786–796 (1997).
14. Mashhadi, N. S. et al. Astaxanthin improves glucose metabolism and reduces blood pressure in patients with type 2 diabetes mellitus. Asia Pac. J. Clin. Nutr. 27, 341–346 (2018).
15. Ito, N., Saito, H., Seki, S., Ueda, F. & Asada, T. Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, DoubleBlind, Placebo-Controlled Trial. J. Alzheimers. Dis. 62, 1767–1775 (2018).
16. Nishioka, Y. et al. The antianxiety-like effect of astaxanthin extracted from Paracoccus carotinifaciens. Biofactors 37, 25–30 (2011).
17. Thalbott, S., et al., (2019) Astaxanthin Supplementation Reduces Depression and Fatigue in Healthy Subjects
18. Earnest, C. P., Lupo, M., White, K. M. & Church, T. S. Effect of astaxanthin on cycling time trial performance. Int. J. Sports Med. 32, 882–888 (2011).
19. Polotow, T. G. et al. Astaxanthin Supplementation Delays Physical Exhaustion and Prevents Redox Imbalances in Plasma and Soleus Muscles of Wistar Rats. Nutrients 6, 5819 (2014).
20. Liu, S. Z. et al. Building strength, endurance, and mobility using an astaxanthin formulation with functional training in elderly. J. Cachexia Sarcopenia Muscle 9, 826–833 (2018).
21. Ito, N., Seki, S. & Ueda, F. The Protective Role of Astaxanthin for UV-Induced Skin Deterioration in Healthy People—A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients vol. 10 817 (2018).
22. Talbott, S. M. et al. Effect of Astaxanthin Supplementation on Psychophysiological Heart-Brain Axis Dynamics in Healthy Subjects. Functional Foods in Health and Disease vol. 9 521 (2019).
23. Malmsten, C., et al., Dietary Supplementation with Astaxanthin-Rich Algal Meal Improves Strength Endurance
24. Capelli, B., et.al. (2016) The Anti-Aging Benefits of Astaxanthin and How it Can Protect our Cells and DNA
25. New study shows Astaxanthin is effective against daily mental and physical fatigue
26. pubmeddev & Imai A, E. al. Effects of Dietary Supplementation of Astaxanthin and Sesamin on Daily Fatigue: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover S… – PubMed – NCBI.
27. Clinical study shows AstaReal® astaxanthin effective in reducing both mental and physical fatigue – AstaReal.
28. Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. J. Nutr. Biochem. 21, 381–389 (2010).
29. Capelli, B., et.al. (2016) The Anti-Aging Benefits of Astaxanthin and How it Can Protect our Cells and DNA .
30. Chowanadisai, W. et al. Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression. J. Biol. Chem. 285, 142–152 (2010).
31. Hwang, P. & Willoughby, D. S. Mechanisms Behind Pyrroloquinoline Quinone Supplementation on Skeletal Muscle Mitochondrial Biogenesis: Possible Synergistic Effects with Exercise. J. Am. Coll. Nutr. 1– 11 (2018).
32. Harris, C. B. et al. Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. J. Nutr. Biochem. 24, 2076–2084 (2013).
33. pubmeddev & Harris CB, E. al. Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. – PubMed – NCBI.
34. Nakano, M., Yamamoto, T., Okamura, H., Tsuda, A. & Kowatari, Y. Effects of Oral Supplementation with Pyrroloquinoline Quinone on Stress, Fatigue, and Sleep. Functional Foods in Health and Disease 2, 307– 324 (2012).
35. pubmeddev & Takatsu H, E. al. Effect of vitamin E on learning and memory deficit in aged rats. – PubMed – NCBI.
36. pubmeddev & Bauerly K, E. al. Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats. – PubMed – NCBI.
37. pubmeddev & Muoio D M And. Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease. – PubMed – NCBI.
38. pubmeddev & Steinberg F, E. al. Pyrroloquinoline quinone improves growth and reproductive performance in mice fed chemically defined diets. – PubMed – NCBI.
39. pubmeddev & Jin X, E. al. Ginseng consumption and risk of cancer: A meta-analysis. – PubMed – NCBI.
40. Kim, J. Y., Park, J. Y., Kang, H. J., Kim, O. Y. & Lee, J. H. Beneficial effects of Korean red ginseng on lymphocyte DNA damage, antioxidant enzyme activity, and LDL oxidation in healthy participants: a randomized, double-blind, placebo-controlled trial. Nutr. J. 11, 47 (2012).
41. pubmeddev & Nocerino E, E. al. The aphrodisiac and adaptogenic properties of ginseng. – PubMed – NCBI.
42. pubmeddev & Chanana P And Kumar. GABA-BZD Receptor Modulating Mechanism of Panax quinquefolius against 72-h Sleep Deprivation Induced Anxiety like Behavior: Possible Roles of Oxida… – PubMed – NCBI.
43. Ginseng protein protects against mitochondrial dysfunction and neurodegeneration by inducing mitochondrial unfolded protein response in Drosophila melanogaster PINK1 model of Parkinson’s disease. J. Ethnopharmacol. 247, 112213 (2020).
44. pubmeddev & Dong GZ, E. al. Red ginseng abrogates oxidative stress via mitochondria protection mediated by LKB1-AMPK pathway. – PubMed – NCBI. .
45. pubmeddev & Wiklund IK, E. al. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, plac… – PubMed – NCBI.
46. pubmeddev & Scaglione F, E. al. Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the… – PubMed – NCBI.
47. Coleman, C. I., Hebert, J. H. & Reddy, P. The effects of Panax ginseng on quality of life. J. Clin. Pharm. Ther. 28, 5–15 (2003).
48. Kim, J.-H. Pharmacological and medical applications of and ginsenosides: a review for use in cardiovascular diseases. J. Ginseng Res. 42, 264–269 (2018).
49. Lee, S.-T., Chu, K., Sim, J.-Y., Heo, J.-H. & Kim, M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 22, 222–226 (2008).
50. Lho, S. K. et al. Effects of lifetime cumulative ginseng intake on cognitive function in late life. Alzheimers. Res. Ther. 10, 50 (2018).
51. pubmeddev & Lee N, E. al. Anti-Fatigue Effects of Enzyme-Modified Ginseng Extract: A Randomized, Double-Blind, Placebo-Controlled Trial. – PubMed – NCBI
52. Barton, D. L. et al. Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2. JNCI Journal of the National Cancer Institute 105, 1230 (2013).
53. Kim, H.-G. et al. Antifatigue Effects of Panax ginseng C.A. Meyer: A Randomised, Double-Blind, PlaceboControlled Trial. PLoS One 8, (2013).
54. Bach, H. V., Kim, J., Myung, S.-K. & Cho, Y. A. Efficacy of Ginseng Supplements on Fatigue and Physical Performance: a Meta-analysis. J. Korean Med. Sci. 31, 1879 (2016).
55. [No title]. https://www.fasebj.org/doi/abs/10.1096/fasebj.25.1_supplement.599.192758/.
56. Ng, T. B. & Wang, H. X. Pharmacological actions of Cordyceps, a prized folk medicine. J. Pharm. Pharmacol. 57, 1509–1519 (2005).
57. Lin, B.-Q. & Li, S.-P. Cordyceps as an Herbal Drug. in Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition (CRC Press/Taylor & Francis, 2011).
58. pubmeddev & Kuo YC, E. al. Cordyceps sinensis as an immunomodulatory agent. – PubMed – NCBI. https://www.ncbi.nlm.nih.gov/pubmed/8874668.
59. pubmeddev & Lo HC, E. al. The anti-hyperglycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide and streptozotocin. – PubMed – NCBI.
61. Hirsch, K. R., Smith-Ryan, A. E., Roelofs, E. J., Trexler, E. T. & Mock, M. G. Cordyceps militaris improves tolerance to high intensity exercise after acute and chronic supplementation. J. Diet. Suppl. 14, 42 (2017).
62. Bird, S. P. Creatine supplementation and exercise performance: a brief review. J. Sports Sci. Med. 2, 123– 132 (2003).
63. Jagim, A. R., Stecker, R. A., Harty, P. S., Erickson, J. L. & Kerksick, C. M. Safety of Creatine Supplementation in Active Adolescents and Youth: A Brief Review. Front Nutr 5, 115 (2018).
64. Vukovich, M. D. & Peeters, B. M. EFFECTS OF CREATINE SUPPLEMENTATION ON EXERCISE PERFORMANCE: A META-ANALYTICAL REVIEW. Medicine & Science in Sports & Exercise vol. 31 S263 (1999).
65. Chilibeck, P. D., Kaviani, M., Candow, D. G. & Zello, G. A. Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. Open Access J Sports Med 8, 213–226 (2017).
66. Barbieri, E. et al. Creatine Prevents the Structural and Functional Damage to Mitochondria in Myogenic, Oxidatively Stressed C2C12 Cells and Restores Their Differentiation Capacity. Oxidative Medicine and Cellular Longevity vol. 2016 1–12 (2016).
67. Avgerinos, K. I., Spyrou, N., Bougioukas, K. I. & Kapogiannis, D. Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials. Exp. Gerontol. 108, 166–173 (2018).
68. Rawson, E. S. & Venezia, A. C. Use of creatine in the elderly and evidence for effects on cognitive function in young and old. Amino Acids 40, 1349–1362 (2011).
69. Korpacheva, O. V., Dolgikh, V. T., Shikunova, L. G. & Zolotov, A. N. [Cardioprotective effect of exogenous creatine phosphate in acute hemorrhage]. Anesteziol. Reanimatol. 13–16 (2002).
70. Study links nutritional supplement, creatine, to increased metabolic energy. EurekAlert!
71. Bondonno, C. P., Croft, K. D. & Hodgson, J. M. Dietary Nitrate, Nitric Oxide, and Cardiovascular Health. Crit. Rev. Food Sci. Nutr. 56, 2036–2052 (2016).
72. Bondonno, C. P. et al. Vegetable-derived bioactive nitrate and cardiovascular health. Mol. Aspects Med. 61, 83–91 (2018).
73. Stanaway, L., Rutherfurd-Markwick, K., Page, R. & Ali, A. Performance and Health Benefits of Dietary Nitrate Supplementation in Older Adults: A Systematic Review. Nutrients 9, (2017).
74. Jones, A. M., Thompson, C., Wylie, L. J. & Vanhatalo, A. Dietary Nitrate and Physical Performance. Annu. Rev. Nutr. 38, 303–328 (2018).
75. Mahoney, D. E. et al. Understanding D-Ribose and Mitochondrial Function. Adv Biosci Clin Med 6, 1–5 (2018).
76. Omran, H., Illien, S., MacCarter, D., St Cyr, J. & Lüderitz, B. D-Ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility study. Eur. J. Heart Fail. 5, 615– 619 (2003).
77. MacCarter, D. et al. D-ribose aids advanced ischemic heart failure patients. Int. J. Cardiol. 137, 79–80 (2009).
78. Pliml, W. et al. Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. Lancet 340, 507–510 (1992).
79. Hellsten, Y., Skadhauge, L. & Bangsbo, J. Effect of ribose supplementation on resynthesis of adenine nucleotides after intense intermittent training in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R182–8 (2004).
80. Seifert, J. G., Brumet, A. & St Cyr, J. A. The influence of D-ribose ingestion and fitness level on performance and recovery. J. Int. Soc. Sports Nutr. 14, 47 (2017).
81. Teitelbaum, J. E., Johnson, C. & St Cyr, J. The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. J. Altern. Complement. Med. 12, 857–862 (2006).
82. Gebhart, B. & Jorgenson, J. A. Benefit of ribose in a patient with fibromyalgia. Pharmacotherapy 24, 1646–1648 (2004).
83. Cordero, M. D. et al. Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia. Clin. Biochem. 42, 732–735 (2009).
84. Di Pierro, F., Rossi, A., Consensi, A., Giacomelli, C. & Bazzichi, L. Role for a water-soluble form of CoQ10 in female subjects affected by fibromyalgia. A preliminary study. Clin. Exp. Rheumatol. 35 Suppl 105, 20–27 (2017).
85. Cordero, M. D. et al. Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia? Antioxid. Redox Signal. 19, 1356–1361 (2013).
86. Jafari, M., Mousavi, S. M., Asgharzadeh, A. & Yazdani, N. Coenzyme Q10 in the treatment of heart failure: A systematic review of systematic reviews. Indian Heart J. 70 Suppl 1, S111–S117 (2018).
87. DiNicolantonio, J. J., Bhutani, J., McCarty, M. F. & O’Keefe, J. H. Coenzyme Q10 for the treatment of heart failure: a review of the literature. Open Heart 2, e000326 (2015).
88. Sanoobar, M., Dehghan, P., Khalili, M., Azimi, A. & Seifar, F. Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial. Nutr. Neurosci. 19, 138– 143 (2016).
89. Sanoobar, M. et al. Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial. Nutr. Neurosci. 18, 169– 176 (2015).
90. Lafuente, R. et al. Coenzyme Q10 and male infertility: a meta-analysis. J. Assist. Reprod. Genet. 30, 1147– 1156 (2013).
91. Xu, Y. et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in lowprognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod. Biol. Endocrinol. 16, 29 (2018).
92. Ben-Meir, A. et al. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell 14, 887–895 (2015).
93. Shoeibi, A. et al. Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial. Acta Neurol. Belg. 117, 103–109 (2017).
94. Sándor, P. S. et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 64, 713–715 (2005).
95. Deichmann, R., Lavie, C. & Andrews, S. Coenzyme q10 and statin-induced mitochondrial dysfunction. Ochsner J. 10, 16–21 (2010).
96. Skarlovnik, A., Janić, M., Lunder, M., Turk, M. & Šabovič, M. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Med. Sci. Monit. 20, 2183–2188 (2014).
97. Kasper, S. & Dienel, A. Multicenter, open-label, exploratory clinical trial with extract in patients suffering from burnout symptoms. Neuropsychiatr. Dis. Treat. 13, 889–898 (2017).
98. Anghelescu, I.-G., Edwards, D., Seifritz, E. & Kasper, S. Stress management and the role of Rhodiola rosea: a review. Int. J. Psychiatry Clin. Pract. 1–11 (2018).
99. McCarty, M. F. Clinical potential of Spirulina as a source of phycocyanobilin. J. Med. Food 10, 566–570 (2007).
100. Nawrocka, D., Kornicka, K., Śmieszek, A. & Marycz, K. Spirulina platensis Improves Mitochondrial Function Impaired by Elevated Oxidative Stress in Adipose-Derived Mesenchymal Stromal Cells (ASCs) and Intestinal Epithelial Cells (IECs), and Enhances Insulin Sensitivity in Equine Metabolic Syndrome (EMS) Horses. Mar. Drugs 15, (2017).
101. Zheng, J. et al. Phycocyanin and phycocyanobilin from Spirulina platensis protect against diabetic nephropathy by inhibiting oxidative stress. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R110–20 (2013).
102. Saha, S. K., Misbahuddin, M., Khatun, R. & Mamun, I. R. Effect of hexane extract of spirulina in the removal of arsenic from isolated liver tissues of rat. Mymensingh Med. J. 14, 191–195 (2005).
103. Saha, S. K., Misbahuddin, M. & Ahmed, A. U. Comparison between the effects of alcohol and hexane extract of spirulina in arsenic removal from isolated tissues. Mymensingh Med. J. 19, 27–31 (2010).
104. pubmeddev & Wu LC, E. al. Antioxidant and antiproliferative activities of Spirulina and Chlorella water extracts. – PubMed – NCBI.
105. pubmeddev & Johnson M, E. al. A randomized, double blind, placebo controlled study of spirulina supplementation on indices of mental and physical fatigue in men. – PubMed – NCBI.
106. pubmeddev & Kalafati M, E. al. Ergogenic and antioxidant effects of spirulina supplementation in humans. – PubMed – NCBI.
107. Ng, Q. X., Koh, S. S. H., Chan, H. W. & Ho, C. Y. X. Clinical Use of Curcumin in Depression: A Meta-Analysis. J. Am. Med. Dir. Assoc. 18, 503–508 (2017).
108. Noorafshan, A., Vafabin, M., Karbalay-Doust, S. & Asadi-Golshan, R. Efficacy of Curcumin in the Modulation of Anxiety Provoked by Sulfite, a Food Preservative, in Rats. Prev Nutr Food Sci 22, 144–148 (2017).
109. Hewlings, S. J. & Kalman, D. S. Curcumin: A Review of Its’ Effects on Human Health. Foods 6, (2017).
110. Soto-Urquieta, M. G. et al. Curcumin restores mitochondrial functions and decreases lipid peroxidation in liver and kidneys of diabetic db/db mice. Biol. Res. 47, 74 (2014).
111. Curcumin, mitochondrial biogenesis, and mitophagy: Exploring recent data and indicating future needs. Biotechnol. Adv. 34, 813–826 (2016).
112. Jamwal, R. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. J. Integr. Med. 16, 367–374 (2018).
113. de Oliveira, M. R. et al. Quercetin and the mitochondria: A mechanistic view. Biotechnol. Adv. 34, 532– 549 (2016).
114. Davis, J. M., Murphy, E. A., Carmichael, M. D. & Davis, B. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R1071– 7 (2009).
115. Ripps, H. & Shen, W. Review: taurine: a ‘very essential’ amino acid. Mol. Vis. 18, 2673–2686 (2012).
116. Scicchitano, B. M. & Sica, G. The Beneficial Effects of Taurine to Counteract Sarcopenia. Curr. Protein Pept. Sci. 19, 673–680 (2018).
117. Schaffer, S. & Kim, H. W. Effects and Mechanisms of Taurine as a Therapeutic Agent. Biomol. Ther. 26, 225–241 (2018).
118. Jong, C. J., Ito, T., Prentice, H., Wu, J.-Y. & Schaffer, S. W. Role of Mitochondria and Endoplasmic Reticulum in Taurine-Deficiency-Mediated Apoptosis. Nutrients 9, (2017).
119. Hansen, S. H., Andersen, M. L., Cornett, C., Gradinaru, R. & Grunnet, N. A role for taurine in mitochondrial function. J. Biomed. Sci. 17 Suppl 1, S23 (2010).
120. Schwalfenberg, G. K. & Genuis, S. J. The Importance of Magnesium in Clinical Healthcare. Scientifica 2017, 4179326 (2017).
121. Veronese, N. et al. Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis. Psychosom. Med. 80, 154–159 (2018).
122. Rump, T. J. et al. Acetyl-L-carnitine protects neuronal function from alcohol-induced oxidative damage in the brain. Free Radic. Biol. Med. 49, 1494–1504 (2010).
123. Scafidi, S., Racz, J., Hazelton, J., McKenna, M. C. & Fiskum, G. Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain. Dev. Neurosci. 32, 480–487 (2010).
124. Xu, Y. et al. L-carnitine treatment of insulin resistance: A systematic review and meta-analysis. Adv. Clin. Exp. Med. 26, 333–338 (2017).
125. Song, X. et al. Efficacy and Safety of L-Carnitine Treatment for Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials. Biomed Res. Int. 2017, 6274854 (2017).
126. Shang, R., Sun, Z. & Li, H. Effective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysis. BMC Cardiovasc. Disord. 14, 88 (2014).
127. Rai, G. et al. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer’s dementia. Curr. Med. Res. Opin. 11, 638–647 (1990).
128. Passeri, M. et al. Acetyl-L-carnitine in the treatment of mildly demented elderly patients. Int. J. Clin. Pharmacol. Res. 10, 75–79 (1990).
129. Thal, L. J. et al. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer’s disease. Neurology 47, 705–711 (1996).
130. Tomassini, V. et al. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J. Neurol. Sci. 218, 103–108 (2004).
131. Plioplys, A. V. & Plioplys, S. Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome. Neuropsychobiology 35, 16–23 (1997).
132. Nicassio, L. et al. Dietary supplementation with acetyl-l-carnitine counteracts age-related alterations of mitochondrial biogenesis, dynamics and antioxidant defenses in brain of old rats. Exp. Gerontol. 98, 99– 109 (2017).
133. Patel, S. P., Sullivan, P. G., Lyttle, T. S. & Rabchevsky, A. G. Acetyl-L-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury. J. Neurochem. 114, 291–301 (2010).
134. Rosca, M. G., Lemieux, H. & Hoppel, C. L. Mitochondria in the elderly: Is acetylcarnitine a rejuvenator? Adv. Drug Deliv. Rev. 61, 1332–1342 (2009).
135. Carrasco-Gallardo, C., Guzmán, L. & Maccioni, R. B. Shilajit: a natural phytocomplex with potential procognitive activity. Int. J. Alzheimers. Dis. 2012, 674142 (2012).
136. Surapaneni, D. K. et al. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats. J. Ethnopharmacol. 143, 91–99 (2012).
137. Heber, D. Pomegranate Ellagitannins. in Herbal Medicine: Biomolecular and Clinical Aspects (eds. Benzie, I. F. F. & Wachtel-Galor, S.) (CRC Press/Taylor & Francis, 2012).
138. Ismail, T. et al. Ellagitannins in Cancer Chemoprevention and Therapy. Toxins 8, (2016).
139. Rodriguez, J. et al. Urolithin B, a newly identified regulator of skeletal muscle mass. J. Cachexia Sarcopenia Muscle 8, 583–597 (2017).
140. Zhao, W. et al. Metabolite of ellagitannins, urolithin A induces autophagy and inhibits metastasis in human sw620 colorectal cancer cells. Mol. Carcinog. 57, 193–200 (2018).
141. Shay, K. P., Moreau, R. F., Smith, E. J., Smith, A. R. & Hagen, T. M. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim. Biophys. Acta 1790, 1149–1160 (2009).
142. Poon, H. F. et al. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alphalipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem. Int. 46, 159– 168 (2005).
143. Panigrahi, M. et al. alpha-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats. Brain Res. 717, 184–188 (1996).
144. Arivazhagan, P., Shila, S., Kumaran, S. & Panneerselvam, C. Effect of DL-alpha-lipoic acid on the status of lipid peroxidation and antioxidant enzymes in various brain regions of aged rats. Exp. Gerontol. 37, 803– 811 (2002).
145. Zhang, L. et al. Alpha-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway. Neurosci. Lett. 312, 125–128 (2001).
146. Breithaupt-Grögler, K. et al. Dose-proportionality of oral thioctic acid–coincidence of assessments via pooled plasma and individual data. Eur. J. Pharm. Sci. 8, 57–65 (1999).
147. Freisleben, H. J., Neeb, A., Lehr, F. & Ackermann, H. Influence of selegiline and lipoic acid on the life expectancy of immunosuppressed mice. Arzneimittelforschung 47, 776–780 (1997).
148. Tejada, S. et al. Potential Anti-inflammatory Effects of Hesperidin from the Genus Citrus. Curr. Med. Chem. 25, 4929–4945 (2018).
149. Manchope, M. F., Casagrande, R. & Verri, W. A., Jr. Naringenin: an analgesic and anti-inflammatory citrus flavanone. Oncotarget 8, 3766–3767 (2017).
150. Benavente-García, O. & Castillo, J. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J. Agric. Food Chem. 56, 6185–6205 (2008).
151. Kumar, A., Prakash, A. & Dogra, S. Naringin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress induced by D-galactose in mice. Food Chem. Toxicol. 48, 626–632 (2010).
152. Singhal, K., Raj, N., Gupta, K. & Singh, S. Probable benefits of green tea with genetic implications. J. Oral Maxillofac. Pathol. 21, 107–114 (2017).
153. Suzuki, Y., Miyoshi, N. & Isemura, M. Health-promoting effects of green tea. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 88, 88–101 (2012).
154. Chacko, S. M., Thambi, P. T., Kuttan, R. & Nishigaki, I. Beneficial effects of green tea: a literature review. Chin. Med. 5, 13 (2010).
155. Ortiz-López, L. et al. Green tea compound epigallo-catechin-3-gallate (EGCG) increases neuronal survival in adult hippocampal neurogenesis in vivo and in vitro. Neuroscience 322, 208–220 (2016).
156. Pervin, M. et al. Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases. Molecules 23, (2018).
157. Babu, P. V. A. & Liu, D. Green tea catechins and cardiovascular health: an update. Curr. Med. Chem. 15, 1840–1850 (2008).
158. Bhardwaj, P. & Khanna, D. Green tea catechins: defensive role in cardiovascular disorders. Chin. J. Nat. Med. 11, 345–353 (2013).
159. Rains, T. M., Agarwal, S. & Maki, K. C. Antiobesity effects of green tea catechins: a mechanistic review. J. Nutr. Biochem. 22, 1–7 (2011).
160. Hursel, R. & Westerterp-Plantenga, M. S. Catechin- and caffeine-rich teas for control of body weight in humans. Am. J. Clin. Nutr. 98, 1682S–1693S (2013).
161. Hursel, R., Viechtbauer, W. & Westerterp-Plantenga, M. S. The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int. J. Obes. 33, 956–961 (2009).
162. Cooper, R., Morré, D. J. & Morré, D. M. Medicinal benefits of green tea: part II. review of anticancer properties. J. Altern. Complement. Med. 11, 639–652 (2005).
163. Lambert, J. D. Does tea prevent cancer? Evidence from laboratory and human intervention studies. Am. J. Clin. Nutr. 98, 1667S–1675S (2013).
164. Park, J.-H., Bae, J.-H., Im, S.-S. & Song, D.-K. Green tea and type 2 diabetes. Integr Med Res 3, 4–10 (2014).
165. Forester, S. C. & Lambert, J. D. The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Mol. Nutr. Food Res. 55, 844–854 (2011).
166. Ohishi, T., Goto, S., Monira, P., Isemura, M. & Nakamura, Y. Anti-inflammatory Action of Green Tea. Antiinflamm. Antiallergy Agents Med. Chem. 15, 74–90 (2016).
167. Bernatoniene, J. & Kopustinskiene, D. M. The Role of Catechins in Cellular Responses to Oxidative Stress. Molecules 23, (2018).
168. Greg Kelly. ND, (2019) NAD: INTRODUCTION TO AN IMPORTANT HEALTHSPAN MOLECULE
169. Klimova, B., Novotny, M. & Kuca, K. Anti-Aging Drugs – Prospect of Longer Life? Curr. Med. Chem. 25, 1946–1953 (2018).
170. Park, A. Scientists Can Reverse DNA Aging in Mice. Time https://time.com/4711023/how-to-keep-yourdna-from-aging/ (2017).
171. Dölle, C., Skoge, R. H., Vanlinden, M. R. & Ziegler, M. NAD biosynthesis in humans–enzymes, metabolites and therapeutic aspects. Curr. Top. Med. Chem. 13, 2907–2917 (2013).
172. pubmeddev & de Andrade KQ, E. al. Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine. – PubMed – NCBI.
173. pubmeddev & Rushworth G F And. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. – PubMed – NCBI.
174. pubmeddev & Elbini Dhouib I, E. al. A minireview on N-acetylcysteine: An old drug with new approaches. – PubMed – NCBI.
175. pubmeddev & Fernandes BS, E. al. N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis. – PubMed – NCBI.
176. pubmeddev & Afshar H, E. al. N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial. – PubMed – NCBI.
177. pubmeddev & Hardan AY, E. al. A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. – PubMed – NCBI.
178. pubmeddev & Magalhães PV, E. al. N-acetylcysteine for major depressive episodes in bipolar disorder. – PubMed – NCBI. https://www.ncbi.nlm.nih.gov/pubmed/22189927.
179. pubmeddev & Kelly MK, E. al. Effects of N-acetylcysteine on respiratory muscle fatigue during heavy exercise. – PubMed – NCBI.
180. Fries, G. R. & Kapczinski, F. N-acetylcysteine as a mitochondrial enhancer: a new class of psychoactive drugs? Braz. J. Psychiatry 33, 321–322 (2011).
181. Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases. Med. Hypotheses 56, 472–477 (2001).
182. Protective effects of N-acetyl-cysteine in mitochondria bioenergetics, oxidative stress, dynamics and S-glutathionylation alterations in acute kidney damage induced by folic acid. Free Radical Biology and Medicine 130, 379–396 (2019).
183. Pezzuto, J. M. Resveratrol: Twenty Years of Growth, Development and Controversy. Biomol. Ther. 27, 1–14 (2019).
184. M Andrea Markus, B. J. M. Resveratrol in prevention and treatment of common clinical conditions of aging. Clin. Interv. Aging 3, 331 (2008).
185. Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α. Cell 127, 1109–1122 (2006).
186. Maroon, J. The Longevity Factor: How Resveratrol and Red Wine Activate Genes for a Longer and Healthier Life. (Simon and Schuster, 2008).
187. Evans, H., Howe, P. & Wong, R. Clinical Evaluation of Effects of Chronic Resveratrol Supplementation on Cerebrovascular Function, Cognition, Mood, Physical Function and General Well- Being in Postmenopausal Women—Rationale and Study Design. Nutrients vol. 8 150 (2016).
188. Grant, R. Resveratrol Increases Intracellular NAD Levels Through Up regulation of The NAD Synthetic Enzyme Nicotinamide Mononucleotide Adenylyltransferase. Nature Precedings (2010) doi:10.1038/npre.2010.4421.1.
189. Carrizzo, A. et al. Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases. Food Chem. Toxicol. 61, 215–226 (2013).
190. Xia, N., Daiber, A., Förstermann, U. & Li, H. Antioxidant effects of resveratrol in the cardiovascular system. Br. J. Pharmacol. 174, 1633–1646 (2017).
191. Omidian, M. et al. The Effects of Resveratrol on Oxidative Stress Markers: A Systematic Review and Meta-Analysis on Randomized Clinical Trials. Endocr. Metab. Immune Disord. Drug Targets (2019) doi:10.2174/1871530319666191116112950.
192. Khan, N. et al. Resveratrol and Bioactive Flavonoids in Immune Function. Dietary Components and Immune Function 397–420 (2010) doi:10.1007/978-1-60761-061-8_23.
193. Inoue, H. & Nakata, R. Resveratrol Targets in Inflammation. Endocrine, Metabolic & Immune Disorders-Drug Targets vol. 15 186–195 (2015).
194. Hurley, L. L., Akinfiresoye, L., Kalejaiye, O. & Tizabi, Y. Antidepressant effects of resveratrol in an animal model of depression. Behavioural Brain Research vol. 268 1–7 (2014).
195. pubmeddev & Lagouge M, E. al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. – PubMed – NCBI.
196. Kan, N.-W. et al. The Synergistic Effects of Resveratrol combined with Resistant Training on Exercise Performance and Physiological Adaption. Nutrients 10, (2018).
197. Alway, S. E. et al. Resveratrol Enhances Exercise-Induced Cellular and Functional Adaptations of Skeletal Muscle in Older Men and Women. J. Gerontol. A Biol. Sci. Med. Sci. 72, 1595–1606 (2017).
198. Scholey, A., Benson, S., Stough, C. & Stockley, C. Effects of resveratrol and alcohol on mood and cognitive function in older individuals. Nutrition and Aging vol. 2 133–138 (2014).
199. Merry, T. L. & Ristow, M. Do antioxidant supplements interfere with skeletal muscle adaptation to exercise training? J. Physiol. 594, 5135–5147 (2016)